✦ LIBER ✦

Dose intensity in lung cancer treatment

✍ Scribed by Cox, J.; Ball, D.; Belani, C.; Choi, N.; Gralla, R.; Halle, J.; Komaki, R.; Le Chevalier, T.; Ohnoshi, T.; Quoix, E.; Ruffié, P.; Shaw, E.; Souhami, R.; Turrisi, A.

Book ID: 123283926
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 209 KB
Volume: 10
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(94)91661-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Importance of dose and dose intensity in

Importance of dose and dose intensity in the treatment of small-cell lung cancer

✍ Nevin Murray 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 131 KB

363 poster workshop Intensity Modulated

363 poster workshop Intensity Modulated Radiation Therapy (IMRT) may improve treatment conformity in dose per fraction dose escalation in patients with unresectable Non-Small-Cell Lung Cancer (NSCLC)

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 123 KB

High dose-intensity chemotherapy, with a

High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer

✍ Ardizzoni, A.; Venturini, M.; Sertoli, M.R.; Penucci, M.C.; Mariani, G.L.; Garro 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 629 KB

Increasing the dose intensity of chemoth

Increasing the dose intensity of chemotherapy by means of granulocyte-colony stimulating factor (G-CSF) support in the treatment of small cell lung cancer (SCLC)

✍ D.J. Girling; N. Thatcher; P.I. Clark; R.J. Stephens 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 140 KB

The feasibility of using glycosylated re

The feasibility of using glycosylated recombinant human granulocyte colonystimulating factor (G-CSF) to increase the planned dose intensity of doxorubicin; cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer

✍ N Thatcher; H Anderson; N.M Bleehen; D.J Girling; G Lallemand; D Machin 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 587 KB

The feasibility of using glycosylated re

The feasibility of using glycosylated recombinant human granulocyte colonystimulating factor (G-CSF) to increase the planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 129 KB